Jeffrey Garber, MD
Family Medicine · Huntsville, ALNPI 1174504740
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 213 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,037 and has fallen 98.1% since, to $20 in 2025.
Across 213 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$570
- AbbVie$347
- Lilly USA, LLC$327
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$255
- AstraZeneca$240
- Novartis$231
- plus $1K from 23 others
Across 15 payments — averaging $5579.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ironwood Pharmaceuticals, Inc$83K
- Vanda Pharmaceuticals Inc.$654
What the payments were for
- Food & beverage$3,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 45 | $570 |
| AbbVie(2 entities) | 31 | $347 |
| Lilly USA, LLC | 15 | $327 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $255 |
| AstraZeneca | 17 | $240 |
| Novartis | 13 | $231 |
| Amarin Pharma, Inc. | 13 | $228 |
| Pfizer | 8 | $194 |
| Sanofi-aventis U.S. LLC | 3 | $155 |
| Esperion Therapeutics, Inc. | 9 | $148 |
| Amgen | 6 | $125 |
| Eisai Inc. | 7 | $89 |
| Astellas Pharma US Inc | 5 | $87 |
| Merck | 5 | $77 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Johnson & Johnson | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 3 | $39 |
| Daiichi Sankyo Inc. | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $29 |
| Boehringer Ingelheim | 2 | $28 |
| Sanofi Pasteur Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Zyla Life Sciences, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DISEASE STATE$125
- EUCRISA$125
How this compares
$3,422 in reported general payments places this provider in the 75th percentile of 1,680 family medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 32 | $527 |
| Amlodipine Besylate | 27 | $255 |
| Gabapentin | 18 | $182 |
| Atorvastatin Calcium | 12 | $161 |
| Pantoprazole Sodium | 14 | $93 |
| Meloxicam | 11 | $89 |
| Hydrochlorothiazide | 19 | $80 |
| Alprazolam | 16 | $46 |
| Fluoxetine Hcl | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Huntsville
- Kathleen DupperHuntsville$210K
- Whitney TewHuntsville$114K
- Daniel EnglertHuntsville$82K
- Jack EnglertHuntsville$37K
- Tobin FisherHuntsville$33K
- David ShowersHuntsville$18K
- Christopher OhalloranHuntsville$18K
- Michael HoneywellHuntsville$17K
- Prasanna AlladaHuntsville$16K
- Lashelle BarmoreBirmingham$486K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.